Jeffrey C. Rathmell PhD

Jeffrey Rathmell, Ph.D., has been recruited to Vanderbilt University Medical Center (VUMC) to lead a new Center for Immunobiology, a structure supported by the Department of Pathology, Microbiology and Immunology, the Department of Medicine and Vanderbilt-Ingram Cancer Center (VICC). Jeffrey Rathmell, Ph.D. He has been named a professor of Pathology, Microbiology and Immunology and will serve as co-leader of the Host Tumor Interactions Research Program at VICC.

Rathmell comes to Vanderbilt from Duke University Medical Center, Durham, North Carolina, where he serves as associate professor of Pharmacology and Cancer Biology and of Immunology in the Duke Molecular Physiology Institute, as well as director of Graduate Studies of Pharmacology. He will join Vanderbilt Sept. 1. “We are very excited to have recruited Jeff to Vanderbilt. He is internationally recognized for his research in the area of immunometabolism, he is an excellent mentor and colleague, and he has outstanding leadership experience in the area of graduate education,” said Eric Skaar, Ph.D., MPH, Ernest W. Goodpasture Professor of Pathology, director of the Division of Host-Pathogen Interactions and associate director of the Vanderbilt Institute of Chemical Biology. In his laboratory research, Rathmell has examined the metabolism of blood cells.